OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Role of hypoxia in the tumor microenvironment and targeted therapy
Gaoqi Chen, Kaiwen Wu, Hao Li, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 62

Showing 1-25 of 62 citing articles:

The Mechanisms of Ferroptosis Under Hypoxia
Xīn Gào, Wei Hu, Dianlun Qian, et al.
Cellular and Molecular Neurobiology (2023) Vol. 43, Iss. 7, pp. 3329-3341
Open Access | Times Cited: 53

Free radicals and their impact on health and antioxidant defenses: a review
Nisansala Chandimali, Seon Gyeong Bak, Eun Hyun Park, et al.
Cell Death Discovery (2025) Vol. 11, Iss. 1
Open Access | Times Cited: 6

Ferroptosis Regulated by Hypoxia in Cells
Xiangnan Zheng, Yuqiong Liang, Cen Zhang
Cells (2023) Vol. 12, Iss. 7, pp. 1050-1050
Open Access | Times Cited: 31

Mechanisms of alkaliptosis
Fangquan Chen, Rui Kang, Jiao Liu, et al.
Frontiers in Cell and Developmental Biology (2023) Vol. 11
Open Access | Times Cited: 27

Targeted modulation of myeloid-derived suppressor cells in the tumor microenvironment: Implications for cancer therapy
Yafeng Qi, Liying Zhang, Y Q Liu, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 180, pp. 117590-117590
Closed Access | Times Cited: 9

Specific changes in amino acid profiles in monocytes of patients with breast, lung, colorectal and ovarian cancers
Vitaliy Chagovets, Natalia Starodubtseva, Alisa Tokareva, et al.
Frontiers in Immunology (2024) Vol. 14
Open Access | Times Cited: 8

On-chip recapitulation of the tumor microenvironment: A decade of progress
Sara Maria Giannitelli, Valentina Peluzzi, Sofia Raniolo, et al.
Biomaterials (2024) Vol. 306, pp. 122482-122482
Open Access | Times Cited: 8

Metabolic crossroads: unravelling immune cell dynamics in gastrointestinal cancer drug resistance
C. Raman Suri, Babita Pande, Lakkakula Suhasini Sahithi, et al.
Cancer Drug Resistance (2025)
Open Access | Times Cited: 1

Molecular and immunological mechanisms of clonal evolution in multiple myeloma
Stefan Förster, Ramin Radpour, Adrian F. Ochsenbein
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 15

Susceptibility of acute myeloid leukemia cells to ferroptosis and evasion strategies
Hanyun Zhang, Chunjie Sun, Qi Sun, et al.
Frontiers in Molecular Biosciences (2023) Vol. 10
Open Access | Times Cited: 13

Research progress in construction of organic carrier drug delivery platform using tumor microenvironment
Han Yan, Pengchao Xu, Hailin Cong, et al.
Materials Today Chemistry (2024) Vol. 37, pp. 101997-101997
Closed Access | Times Cited: 4

Research Developments in Cancer Hallmarks and Immune Checkpoints Based on Mechanisms of Tumour Microenvironment
Chao Jin
Theoretical and Natural Science (2025) Vol. 90, Iss. 1, pp. 38-47
Closed Access

Hypoxia signature derived from tumor-associated endothelial cells predict prognosis in gastric cancer
Ruiheng Wang, Guijun Liu, Ke Wang, et al.
Frontiers in Cell and Developmental Biology (2025) Vol. 13
Open Access

Targeting Metabolic Vulnerabilities to Combat Drug Resistance in Cancer Therapy
Taranatee Khan, M Nagarajan, Irene Kang, et al.
Journal of Personalized Medicine (2025) Vol. 15, Iss. 2, pp. 50-50
Open Access

Advanced Biomarkers and Precision Medicine: Innovative Strategies to Prevent Cancer Recurrence
MS Ganesh, R. Revanth, C. Mahesh Elaya Bharathi
Journal of cancer research updates (2025) Vol. 14, pp. 1-11
Closed Access

Elevated reactive oxygen species can drive the alternative lengthening of telomeres pathway in ATRX-null cancers
Tomas Goncalves, Siobhan Cunniffe, Stephen T. Tiffany, et al.
Nucleic Acids Research (2025) Vol. 53, Iss. 4
Open Access

Spheroid‐on‐a‐Chip Platforms for Tumor Microenvironment and Drug Development
Pierre Claver Uzabakiriho, Jiajun Fan, Benedictor Alexander Nguchu, et al.
Advanced Materials Technologies (2025)
Closed Access

Unlocking the Microbial Symphony: The Interplay of Human Microbiota in Cancer Immunotherapy Response
Jessica Chacon, Farah Faizuddin, J. M. T. McKee, et al.
Cancers (2025) Vol. 17, Iss. 5, pp. 813-813
Open Access

The landscape of research on ferroptosis under hypoxic conditions: a bibliometric analysis
Di Yu, Yibo Hu, Meijuan Ma, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access

Role of metabolic transformation in cancer immunotherapy resistance: molecular mechanisms and therapeutic implications
Sandesh Shende, Jaishriram Rathored, Tanushree Budhbaware
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access

Nanozymes in biomedicine: Unraveling trends, research foci, and future trajectories via bibliometric insights (from 2007 to 2024)
Siyang Cao, Yingchen Pang, Yihao Wei, et al.
International Journal of Biological Macromolecules (2025), pp. 142798-142798
Closed Access

HIF-1 mediated metabolic reprogramming in cancer: Mechanisms and therapeutic implications
Nikita Taneja, Akansha Chauhan, Ritu Kulshreshtha, et al.
Life Sciences (2024) Vol. 352, pp. 122890-122890
Closed Access | Times Cited: 3

Page 1 - Next Page

Scroll to top